Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024) Share, Scope, Revenue, Growth Forecast, Trends, Drivers, Challenges, Segmentation based on Product Type (Testing Strips, Glucometers, Others) End-User Type (Hospitals, Diagnostic Center and Clinics, Home Settings) and Countries (India, China, Australia and New Zealand, Rest of Asia-Pacific)

Array
(
    [id] => 1787827
    [discount] => ENTERPRISE WIDE LICENCE-30--------
    [isbn] => 
    [title] => Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024) Share, Scope, Revenue, Growth Forecast, Trends, Drivers, Challenges, Segmentation based on Product Type (Testing Strips, Glucometers, Others) End-User Type (Hospitals, Diagnostic Center and Clinics, Home Settings) and Countries (India, China, Australia and New Zealand, Rest of Asia-Pacific)
    [upcommingtext] => 
    [seo_url] => asia-pacific-self-monitoring-blood-glucose-devices-market
    [shortdesc] => 
    [meta_title] => Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024) Share, Scope, Revenue, Growth Forecast, Trends, Drivers, Challenges, Segmentation based on Product Type (Testing Strips, Glucometers, Others) End-User Type (Hospitals, Diagnostic Center and Clinics, Home Settings) and Countries (India, China, Australia and New Zealand, Rest of Asia-Pacific)
    [keyword] => Self-monitoring Blood Glucose Devices Market, Asia-Pacific Self-monitoring Blood Glucose Devices Market Analysis, Self-monitoring Blood Glucose Devices Market Growth, Self-monitoring Blood Glucose Devices Market Size
    [description] => Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024) Share, Scope, Revenue, Growth Forecast, Trends, Drivers, Challenges, Segmentation based on Product Type (Testing Strips, Glucometers, Others) End-User Type (Hospitals, Diagnostic Center and Clinics, Home Settings) and Countries (India, China, Australia and New Zealand, Rest of Asia-Pacific) market research report available in single user pdf license with Aarkstore Enterprise at USD 2950
    [curr] => USD
    [category] => 1200
    [publisher] => 48
    [published_date] => 2019-09-02
    [country] => 138
    [author_name] => 
    [page_num] => 70
    [abstract] => 

The Asia-Pacific self-monitoring blood glucose devices market is expected to expand at a CAGR of 6.34% during the 2019-2024 period, owing to technological breakthroughs, rising obesity, and the increasing prevalence of diabetes.
 

Product Segment Insights:
The testing strips segment is expected to hold the highest market share (81.64%) in 2019. Owing to the development of innovative testing strips, and a massive increase in the incidence of diabetes, this segment is expected to witness a high CAGR of 6.94% during the forecast period. The glucometers segment is expected to remain steady while generating 12% of the revenue in the Asia-Pacific market in 2019. Factors like the advantages of glucometers over regular monitoring methodologies and the production of a wide range of devices will drive this segment. However, variations in results due to external and physiological factors will lead to a comparatively low CAGR (4.95%) during the 2019-2024 period.

End User Segment Insights:

The shift of medical services to decentralized surroundings like patients’ homes and the development of portable and user-friendly blood glucose monitoring devices will enable the home settings segment to expand at a CAGR of 6.82% during the 2019-2024 period. The hospitals sector will generate almost 7% of the total market revenue by 2019, and is anticipated to expand at a CAGR of 4.78% during the forecast period.

Country-wise Insights:
China and India account for half of the total diabetic population in the Asia-Pacific region. Advanced medical facilities, awareness programs, and cost-effective treatments to tackle diabetes will transform this region into the fastest-growing SMBG devices market in the world. China is expected to expand at a CAGR of 6.62% during the forecast period, while healthcare initiatives and government programs in India will enable the market in the country to expand at a CAGR of 6.46%.

Companies covered:
• Wockhardt
• Roche Holding
• Abbott Laboratories
• i-SENS
• Terumo Medical
 

[table_of_contents] =>

Chapter 1. Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered in this study
1.3. Executive summary

Chapter 2: Asia-Pacific self-monitoring blood glucose devices market – overview
2.1. Market definitions
2.2. Market overview
- Historical market revenue (USD Bn)
- Forecasted market revenue (USD Bn)
- Country-wise market revenue (USD Bn)
2.3. Market trends
2.4. Market drivers
2.5. Market challenges
2.6. Value chain analysis
2.7. Porter’s five forces analysis

Chapter 3: Asia-Pacific self-monitoring blood glucose devices market – based on products
3.1. Testing strips
- Market overview
- Forecasted market segment revenue (USD Bn)
3.2. Glucometers
- Market overview
- Forecasted market segment revenue (USD Bn)
3.3. ‘Others’
- Market overview
- Forecasted market segment revenue (USD Bn)

Chapter 4: Asia-Pacific self-monitoring blood glucose devices market – based on end users
4.1. Hospitals
- Market overview
- Forecasted market segment revenue (USD Bn)
4.2. Diagnostic centers and clinics
- Market overview
- Forecasted market segment revenue (USD Bn)
4.3. Home settings
- Market overview
- Forecasted market segment revenue (USD Bn)

Chapter 5: India self-monitoring blood glucose devices market
5.1. Overview
- Revenue (USD Bn)
- Forecasted market revenue (USD Bn)
5.2. Trends
5.3. Drivers
5.4. Challenges
5.5. Market observations based on products
- Key market observations
- Forecasted market revenue (USD Bn)
5.6. Market observations based on end users
- Key market observations
- Forecasted market revenue (USD Bn)

Chapter 6: China self-monitoring blood glucose devices market
6.1. Overview
- Revenue (USD Bn)
- Forecasted market revenue (USD Bn)
6.2. Trends
6.3. Drivers
6.4. Challenges
6.5. Market observations based on products
- Key market observations
- Forecasted market revenue (USD Bn)
6.6. Market observations based on end users
- Key market observations
- Forecasted market revenue (USD Bn)

Chapter 7: Australia and New Zealand self-monitoring blood glucose devices market
7.1. Overview
- Revenue (USD Bn)
- Forecasted market revenue (USD Bn)
7.2. Trends
7.3. Drivers
7.4. Challenges
7.5. Market observations based on products
- Key market observations
- Forecasted market revenue (USD Bn)
7.6. Market observations based on end-users
- Key market observations
- Forecasted market revenue (USD Bn)

Chapter 8: Rest of Asia-Pacific self-monitoring blood glucose devices market
8.1. Overview
- Revenue (USD Bn)
- Forecasted market revenue (USD Bn)
8.2. Trends
8.3. Drivers
8.4. Challenges
8.5. Market observations based on products
- Key market observations
- Forecasted market revenue (USD Bn)
8.6. Market observations based on end-users
- Key market observations
- Forecasted market revenue (USD Bn)

Chapter 9: Competitive landscape
9.1. Wockhardt*
- Company snapshot
- Products
- Strategic initiatives
- Countries present
- Key people
9.2. Roche Holding
9.3. Abbott Laboratories
9.4. i-SENS
9.5. Terumo Medical

(*) The coverage approach remains the same for all companies

Chapter 10: Conclusion
10.1. PESTEL analysis
10.2. Impact assessment
10.3. Future outlook

Chapter 11: Appendix
11.1. List of tables
11.2. Assumptions
11.3. Research methodology
11.4. About Research on Global Markets
11.5. Disclaimer
 

[list_of_tables] => [list_of_figures] => [sample_page] => [brochure] => [new_price] => ENTERPRISE WIDE LICENCE-2950 )
discount aarkstore

The Asia-Pacific self-monitoring blood glucose devices market is expected to expand at a CAGR of 6.34% during the 2019-2024 period, owing to technological breakthroughs, rising obesity, and the increasing prevalence of diabetes.
 

Product Segment Insights:
The testing strips segment is expected to hold the highest market share (81.64%) in 2019. Owing to the development of innovative testing strips, and a massive increase in the incidence of diabetes, this segment is expected to witness a high CAGR of 6.94% during the forecast period. The glucometers segment is expected to remain steady while generating 12% of the revenue in the Asia-Pacific market in 2019. Factors like the advantages of glucometers over regular monitoring methodologies and the production of a wide range of devices will drive this segment. However, variations in results due to external and physiological factors will lead to a comparatively low CAGR (4.95%) during the 2019-2024 period.

End User Segment Insights:

The shift of medical services to decentralized surroundings like patients’ homes and the development of portable and user-friendly blood glucose monitoring devices will enable the home settings segment to expand at a CAGR of 6.82% during the 2019-2024 period. The hospitals sector will generate almost 7% of the total market revenue by 2019, and is anticipated to expand at a CAGR of 4.78% during the forecast period.

Country-wise Insights:
China and India account for half of the total diabetic population in the Asia-Pacific region. Advanced medical facilities, awareness programs, and cost-effective treatments to tackle diabetes will transform this region into the fastest-growing SMBG devices market in the world. China is expected to expand at a CAGR of 6.62% during the forecast period, while healthcare initiatives and government programs in India will enable the market in the country to expand at a CAGR of 6.46%.

Companies covered:
• Wockhardt
• Roche Holding
• Abbott Laboratories
• i-SENS
• Terumo Medical
 

Chapter 1. Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered in this study
1.3. Executive summary

Chapter 2: Asia-Pacific self-monitoring blood glucose devices market – overview
2.1. Market definitions
2.2. Market overview
- Historical market revenue (USD Bn)
- Forecasted market revenue (USD Bn)
- Country-wise market revenue (USD Bn)
2.3. Market trends
2.4. Market drivers
2.5. Market challenges
2.6. Value chain analysis
2.7. Porter’s five forces analysis

Chapter 3: Asia-Pacific self-monitoring blood glucose devices market – based on products
3.1. Testing strips
- Market overview
- Forecasted market segment revenue (USD Bn)
3.2. Glucometers
- Market overview
- Forecasted market segment revenue (USD Bn)
3.3. ‘Others’
- Market overview
- Forecasted market segment revenue (USD Bn)

Chapter 4: Asia-Pacific self-monitoring blood glucose devices market – based on end users
4.1. Hospitals
- Market overview
- Forecasted market segment revenue (USD Bn)
4.2. Diagnostic centers and clinics
- Market overview
- Forecasted market segment revenue (USD Bn)
4.3. Home settings
- Market overview
- Forecasted market segment revenue (USD Bn)

Chapter 5: India self-monitoring blood glucose devices market
5.1. Overview
- Revenue (USD Bn)
- Forecasted market revenue (USD Bn)
5.2. Trends
5.3. Drivers
5.4. Challenges
5.5. Market observations based on products
- Key market observations
- Forecasted market revenue (USD Bn)
5.6. Market observations based on end users
- Key market observations
- Forecasted market revenue (USD Bn)

Chapter 6: China self-monitoring blood glucose devices market
6.1. Overview
- Revenue (USD Bn)
- Forecasted market revenue (USD Bn)
6.2. Trends
6.3. Drivers
6.4. Challenges
6.5. Market observations based on products
- Key market observations
- Forecasted market revenue (USD Bn)
6.6. Market observations based on end users
- Key market observations
- Forecasted market revenue (USD Bn)

Chapter 7: Australia and New Zealand self-monitoring blood glucose devices market
7.1. Overview
- Revenue (USD Bn)
- Forecasted market revenue (USD Bn)
7.2. Trends
7.3. Drivers
7.4. Challenges
7.5. Market observations based on products
- Key market observations
- Forecasted market revenue (USD Bn)
7.6. Market observations based on end-users
- Key market observations
- Forecasted market revenue (USD Bn)

Chapter 8: Rest of Asia-Pacific self-monitoring blood glucose devices market
8.1. Overview
- Revenue (USD Bn)
- Forecasted market revenue (USD Bn)
8.2. Trends
8.3. Drivers
8.4. Challenges
8.5. Market observations based on products
- Key market observations
- Forecasted market revenue (USD Bn)
8.6. Market observations based on end-users
- Key market observations
- Forecasted market revenue (USD Bn)

Chapter 9: Competitive landscape
9.1. Wockhardt*
- Company snapshot
- Products
- Strategic initiatives
- Countries present
- Key people
9.2. Roche Holding
9.3. Abbott Laboratories
9.4. i-SENS
9.5. Terumo Medical

(*) The coverage approach remains the same for all companies

Chapter 10: Conclusion
10.1. PESTEL analysis
10.2. Impact assessment
10.3. Future outlook

Chapter 11: Appendix
11.1. List of tables
11.2. Assumptions
11.3. Research methodology
11.4. About Research on Global Markets
11.5. Disclaimer
 


2020 Asia-Pacific Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: A 17-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies,Instrumentation and Opportunities

This new 17-country report is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and evaluate

USD 9500 View Report

Asia-Pacific Tumor Markers Sales Segment Forecasts for over 40 Tests: A 17-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Tests, Technologies and Opportunities

This new 17-country report is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to

USD 14500 View Report

Global Self-Monitoring Blood Glucose (SMBG) Devices Market Research Report 2020-2024

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Self-Monitoring Blood Glucose (SMBG) Devices Report by Material,

USD 2850 View Report

Europe Self-Monitoring Blood Glucose Strips Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Self-Monitoring Blood Glucose Strips market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available